This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gennari, L. Articles by Brandi, M. L. Search for Related Content PubMed PubMed Citation Articles by Gennari, L. Articles by Brandi, M. L.

Vitamin D and Estrogen Receptor Allelic Variants in Italian Postmenopausal Women: Evidence of Multiple Gene Contribution to Bone Mineral Density

Departments of Clinical Physiopathology (L.G., L.B., L.M., R.M., M.L.B.) and of Obstetricts and Ginecology (G.L., A.M.B)., University of Florence, 50139 Florence; and Institute of Medical Pathology (S.G., C.C., S.M., A.M.), University of Siena, Siena, 53100 Italy

Address all correspondence and requests for reprints to: Maria Luisa Brandi, M.D., Ph.D., Endocrine Unit, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Bone mass and bone turnover are under genetic control. Restriction fragment length polymorphisms (RFLPs) at the vitamin D receptor (VDR) gene locus have been recently correlated to bone mineral density (BMD) and rate of bone loss. However, agreement on this relationship is not universal. The existence of ethnical and environmental differences between populations, a health-based selection bias in several previous studies, and the involvement of other genes could explain these discordant findings. In this study, we examined the relationship of VDR and estrogen receptor (ER) gene RFLPs with lumbar spine and upper femur BMD in 426 Italian postmenopausal women, 57.7 ± 0.4 yr old (144 normal, 106 osteopenic, and 176 osteoporotic). VDR gene RFLPs for ApaI, Bsm I, and TaqI restriction endonucleases and ER RFLPs for PvuII and XbaI restriction endonucleases were assessed by Southern blotting analysis and were indicated, respectively, as A-a, B-b, T-t, P-p, and X-x (uppercase letters signifying the absence and lowercase letters the presence of the restriction site). After correcting for potential confounding factors (age, height, weight, age since menopause, osteophytosis, and facet joint osteoarthritis), a statistically significant VDR genotype effect on lumbar BMD (P = 0.01, analysis of covariance), but not on femoral BMD, was detected, with subjects in AABBtt genotype showing a 13% lower BMD than those with aabbTT genotype (P < 0.05, Tukey’s test). Moreover, a statistically significant prevalence of AABBtt genotype in osteoporotics, and of AabbTT and aabbTT genotypes in nonosteoporotics, were detected. Conversely, there was no significant relationship of ER genotype to either lumbar or femoral BMD, even though a trend for higher BMD values in women with the ER PP genotype (with respect to those with ER pp genotype) was detected. When mean lumbar BMD was calculated for women grouped by ER and VDR genotype, we observed a significant difference between those within the 2 opposite associations AABBtt-PPXX and aabbTT-ppxx (0.71 ± 0.05 vs. 0.97 ± 0.03 g/cm², P < 0.05 Tukey’s test). These results are consistent with a segregation of the VDR AABBtt genotype with a higher risk of developing osteoporosis, in the Italian female population. The introduction of another variable, the ER genotype, in the analysis of VDR genetic determination of BMD, may represent a useful model in the identification of patients at risk of developing a multigenic disorder like osteoporosis.

This article has been cited by other articles:

				F. F. Bezerra, G. M. K. Cabello, L. M. C. Mendonca, and C. M. Donangelo Bone Mass and Breast Milk Calcium Concentration Are Associated with Vitamin D Receptor Gene Polymorphisms in Adolescent Mothers J. Nutr., February 1, 2008; 138(2): 277 - 281. [Abstract] [Full Text] [PDF]

				Y. Fang, J. B. J. van Meurs, F. Rivadeneira, N. M. van Schoor, J. P. T. van Leeuwen, P. Lips, H. A. P. Pols, and A. G. Uitterlinden Vitamin D Receptor Gene Haplotype Is Associated with Body Height and Bone Size J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1491 - 1501. [Abstract] [Full Text] [PDF]

				L. Gennari, D. Merlotti, V. De Paola, A. Calabro, L. Becherini, G. Martini, and R. Nuti Estrogen Receptor Gene Polymorphisms and the Genetics of Osteoporosis: A HuGE Review Am. J. Epidemiol., February 15, 2005; 161(4): 307 - 320. [Abstract] [Full Text] [PDF]

				H. S. Kok, N. C. Onland-Moret, K. M. van Asselt, C. H. van Gils, Y. T. van der Schouw, D. E. Grobbee, and P. H.M. Peeters No association of estrogen receptor {alpha} and cytochrome P450c17{alpha} polymorphisms with age at menopause in a Dutch cohort Hum. Reprod., February 1, 2005; 20(2): 536 - 542. [Abstract] [Full Text] [PDF]

				N. Morrison Commentary: Vitamin D receptor polymorphism and bone mineral density: effect size in Caucasians means detection is uncertain in small studies Int. J. Epidemiol., October 1, 2004; 33(5): 989 - 994. [Full Text] [PDF]

				A. Morita, M. Iki, Y. Dohi, Y. Ikeda, S. Kagamimori, Y. Kagawa, T. Matsuzaki, H. Yoneshima, F. Marumo, and for JPOS Study Group Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study Int. J. Epidemiol., October 1, 2004; 33(5): 979 - 988. [Abstract] [Full Text] [PDF]

				S. Khosla, B. L. Riggs, E. J. Atkinson, A. L. Oberg, C. Mavilia, F. Del Monte, L. J. Melton III, and M. L. Brandi Relationship of Estrogen Receptor Genotypes to Bone Mineral Density and to Rates of Bone Loss in Men J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1808 - 1816. [Abstract] [Full Text] [PDF]

				H. Matsushita, T. Kurabayashi, M. Tomita, and K. Tanaka Effects of vitamin D and estrogen receptor gene polymorphisms on the changes in lumbar bone mineral density with multiple pregnancies in Japanese women Hum. Reprod., January 1, 2004; 19(1): 59 - 64. [Abstract] [Full Text] [PDF]

				V. Ferrero, F. Ribichini, G. Matullo, S. Guarrera, S. Carturan, A. Vado, C. Vassanelli, A. Piazza, E. Uslenghi, and W. Wijns Estrogen Receptor-{alpha} Polymorphisms and Angiographic Outcome After Coronary Artery Stenting Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2223 - 2228. [Abstract] [Full Text] [PDF]

				Q. Cai, X.-O. Shu, F. Jin, Q. Dai, W. Wen, J.-R. Cheng, Y.-T. Gao, and W. Zheng Genetic Polymorphisms in the Estrogen Receptor {alpha} Gene and Risk of Breast Cancer: Results from the Shanghai Breast Cancer Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 853 - 859. [Abstract] [Full Text] [PDF]

				E. M. Colin, A. G. Uitterlinden, J. B. J. Meurs, A. P. Bergink, M. Van De Klift, Y. Fang, P. P. Arp, A. Hofman, J. P. T. M. van Leeuwen, and H. A. P. Pols Interaction between Vitamin D Receptor Genotype and Estrogen Receptor {alpha} Genotype Influences Vertebral Fracture Risk J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3777 - 3784. [Abstract] [Full Text] [PDF]

				S. Palomba, F. G. Numis, G. Mossetti, D. Rendina, P. Vuotto, T. Russo, F. Zullo, C. Nappi, and V. Nunziata Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes Hum. Reprod., January 1, 2003; 18(1): 192 - 198. [Abstract] [Full Text] [PDF]

				B. L. Riggs, S. Khosla, and L. J. Melton III Sex Steroids and the Construction and Conservation of the Adult Skeleton Endocr. Rev., June 1, 2002; 23(3): 279 - 302. [Abstract] [Full Text] [PDF]

				P. B Rapuri, J C. Gallagher, H K. Kinyamu, and K. L Ryschon Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes Am. J. Clinical Nutrition, November 1, 2001; 74(5): 694 - 700. [Abstract] [Full Text] [PDF]

				L. Masi, L. Becherini, L. Gennari, A. Amedei, E. Colli, A. Falchetti, M. Farci, S. Silvestri, S. Gonnelli, and M. L. Brandi Polymorphism of the Aromatase Gene in Postmenopausal Italian Women: Distribution and Correlation with Bone Mass and Fracture Risk J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2263 - 2269. [Abstract] [Full Text]

				J. A. Eisman Pharmacogenetics of the Vitamin D Receptor and Osteoporosis Drug Metab. Dispos., April 1, 2001; 29(4): 505 - 512. [Abstract] [Full Text]

				L. Becherini, L. Gennari, L. Masi, R. Mansani, F. Massart, A. Morelli, A. Falchetti, S. Gonnelli, G. Fiorelli, A. Tanini, et al. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor {alpha} gene and their relationship to bone mass variation in postmenopausal Italian women Hum. Mol. Genet., August 12, 2000; 9(13): 2043 - 2050. [Abstract] [Full Text] [PDF]

				E. Weiderpass, I. Persson, H. Melhus, S. Wedren, A. Kindmark, and J. A. Baron Estrogen receptor {alpha} gene polymorphisms and endometrial cancer risk Carcinogenesis, April 1, 2000; 21(4): 623 - 627. [Abstract] [Full Text] [PDF]

				J. A. Eisman Genetics of Osteoporosis Endocr. Rev., December 1, 1999; 20(6): 788 - 804. [Abstract] [Full Text]

				A. E. A. M. Weel, A. G. Uitterlinden, I. C. D. Westendorp, H. Burger, S. C. E. Schuit, A. Hofman, T. J. M. Helmerhorst, J. P. T. M. van Leeuwen, and H. A. P. Pols Estrogen Receptor Polymorphism Predicts the Onset of Natural and Surgical Menopause J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3146 - 3150. [Abstract] [Full Text]